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Sequential Antifouling Surface for Eﬃcient Modulation
of the Nanoparticle–Cell Interactions in Protein-Rich
Environments
Feng Zhang, Li Kong, Dongfei Liu, Wei Li, Ermei Ma¨kila¨, Alexandra Correia, Rici Lindgren,
Jarno Salonen, Jouni J. Hirvonen, Hongbo Zhang, Alexander Kros, and He´lder A. Santos*
Modulating the nanoparticle (NP)–cell interactions in protein-rich
environments is of increasing signiﬁcance to nanomedicine. One major
challenge is that the synthetic identity (such as targeting) of NPs endowed for
this purpose can be adversely altered by opsonization processes. The formed
protein corona on NPs can cause fast clearance of NPs by macrophages and
reduced cancer cell uptake. The transformable NPs, which are grafted with a
cleavable antifouling surface to achieve inactive-active targeting form
conversion, oﬀer great promise to eﬃciently modulate NP–cell interactions.
However, most of the transformable NPs lack a sustainable protection
mechanism to avoid the inﬂuence of the protein corona during the
post-transformation period, leading to the re-opsonization on NPs. Here, the
authors design a smart transformable nanosystem with a photo-triggered
zwitterion-induced sequential antifouling surface to eﬃciently reduce protein
adsorption on NPs and modulate the NP–cell interactions in protein-rich
environments. The authors demonstrate that the primary PEGylated
antifouling surface could protect the NPs against uptake by macrophages.
Furthermore, the photo-induced secondary zwitterionic antifouling surface is
shown to preserve the targeting capacity of biotin-modiﬁed NPs during the
post-transformation period in protein-rich environments. In contrast, the
biotin-conjugated NPs without antifouling surfaces almost lost the targeting
speciﬁcity in protein-rich environment.
1. Introduction
Engineering the surface of nanoparticles (NPs) to target the can-
cer cells is one of the most important aims of nanomedicine.
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In view of the various intrinsic physical
and structural properties, numerous nanos-
tructures have been developed as carriers
for therapeutics to regulate their pharma-
cokinetics and bio-distribution by passive
or active targeting.[1–3] However, this target-
ing capacity can be deprived by the fast op-
sonization process in physiological environ-
ments (e.g. blood, interstitial ﬂuid, and cel-
lular cytoplasm).[4–6] The serum and plasma
proteins deposit on the surface of NPs and
then form protein corona, which can phys-
ically mask the physicochemical properties
of NPs (e.g., material, size, charge, shape,
and surface functional group) and signiﬁ-
cantly alter the fate of NPs, leading to the
loss of targeting speciﬁcity and fast uptake
by macrophages.[7–10] Furthermore, subop-
timal NPs accumulationmediated by the ex-
pression of relevant receptor in normal cells
also leads to the oﬀ-target of NPs.[11,12]
To inhibit the inﬂuence of protein op-
sonization and oﬀ-target eﬀect, as well as
promote the speciﬁcity to cancer cells,many
inactive–active form conversion strategies,
such as uncaging, charge conversion, and
conformation change, have been developed
to modulate the NP–cell interactions in
physiological environments.[13–18] In these system, the antifoul-
ing surfaces (such as PEGylated surface or zwitterionic surface)
act as inactive form to minimize the protein adsorption, reduce
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the macrophages uptake, and prolong the systemic circulation
of the NPs.[19–21] The NPs conversion can be achieved by cleav-
ing the antifouling surface by endogenous signals (such as pH
and enzymes) or exogenous signals (such as photo), to expose
the internal targeting segments for cell recognition. However,
most of these eﬀorts neglected a protection mechanism to guar-
antee the eﬃcient exposure of the targeting segments during
the post-transformation period of NPs in the protein-rich envi-
ronment. As a result, the ensuing re-opsonization occurs to the
NPs, leading to the loss of targeting speciﬁcity for cancer cell
uptake.[9,22,23]
Here, we introduce a sequential antifouling strategy to avoid
the protein adsorption and guarantee the eﬃcient inactive–
active form conversion of NPs in protein-rich environment.
To achieve direct and eﬃcient artiﬁcial modulation, ultravi-
olet (UV) was selected as the trigger for the NPs transfor-
mation. This sequential antifouling surface was constructed
by PEGylation of the polyethylenimine (PEI) surface via a
photocleavable ortho-nitrobenzyl (o-NB) linker, with biotin
conjugated as targeting molecules.[24–26] The o-NB alcohol deriva-
tives have been widely used as crosslinkers to construct pho-
todegradable biomaterials.[27–30] The o-NB-based crosslinkers
can be cleaved rapidly using low-intensity UV light irradia-
tion (1.3 mW cm−2).[27] Moreover, the cleavage of o-NB-based
crosslinkers can also be achieved by two-photon infrared (IR) ex-
citation or NIR-UV upconversion, allowing for deeper tissue pen-
etration and increasing biosafety as compared to UV light.[28,31]
Thus, o-NB-based photodegradable systems have the potential to
achieve noninvasive controlled drug release in deep tissue spa-
tially and temporally. The NPs transformation was achieved by
photo-irradiation, resulting in cleavage of the outer PEG layer and
concomitant formation of carboxylic acids. The generated nega-
tive charged carboxyl groups together with the positive charged
amine groups constructed the zwitterionic surface of the NPs.
This photo-triggered zwitterization process on PEI was accom-
panied by the exposure of biotin, resulting in the inactive–active
targeting conversion. We demonstrated that this inactive–active
targeting transformable delivery system with sequential antifoul-
ing surface has eﬃcient photo-induced multistage NP–cell inter-
actions with diﬀerent kinds of cells (MDA-MB-231 cells, NIH
3T3 ﬁbroblasts, and RAW 267.4 macrophages) in protein-rich
environment.
2. Results and Discussion
2.1. Fabrication and Characterization of the NPs
The synthesis of the photocleavable acrylates-ortho-nitrobenzyl-
PEG5000 construct is outlined in Figure S1, Supporting Informa-
tion. The mPEG5000 for forming protective PEG corona and acry-
late for further modiﬁcation on NPs were added to the nitroben-
zyl alcohol. Both 1H NMR spectrum (Figures S2–S6, Supporting
Information) and MALDI-TOF mass spectrum (Figures S7 and
S8, Supporting Information) conﬁrmed the chemical structures
during the synthesis.
The undecylenic acid–modiﬁed, thermally hydrocarbonized
porous silicon (UnTHCPSi) NPs were used as a delivery sys-
tem because of the available surface sites for chemical graft-
ing and porous structure for loading of various cargos.[32–34] The
polycationic PEI was conjugated onto the surface of UnTHCPSi
by carbodiimide-based coupling reaction. Next, the biotin-N-
hydroxysuccinimide (NHS) ester was used for biotinylation. The
unreacted amine groups of PEI were used for further processing
into the PEGylated and zwitterionic surfaces. Thiolation was per-
formed using Traut’s reagent (2-iminothiolane hydrochloride) in
order to introduce thiol groups required for subsequent conju-
gation of photocleavable PEG segment via a Thiol–Michael ad-
dition click reaction.[35] After PEGylation, the UnTHCPSi-biotin-
PEG-modiﬁedNPs (i.e., UPBPNPs) with PEGylated surface were
obtained. After UV photolysis (wavelength at 365 nm), the ester
bond on the acrylates-ortho-nitrobenzyl segment was cleaved, fol-
lowed by the cleavage of the PEG shield and the generation of a
zwitterionic surface. These photolyzed UPBP NPs with a zwit-
terionic surface were called Un-Bio@ZwS NPs. The fabrication
process of this nanosystem is shown in Scheme 1. Fourier trans-
form infrared (FTIR) spectra were used to conﬁrm the successful
surface modiﬁcation of UnTHCPSi NPs (Figure S9, Supporting
Information).
The time-evolution kinetics of ortho-nitrobenzyl-PEG5000 pho-
tolysis was quantiﬁed by high-performance liquid chromatog-
raphy (HPLC) traces (Figure 1A; Figure S10, Supporting Infor-
mation). We observed that approximately 80% conversion was
achieved within 5 min of irradiation. Next, the UV-irradiation
time-related cell viability and UV-induced DNA damage were
tested on MDA-MB-231 cells, NIH 3T3 ﬁbroblast, and renal ep-
ithelial cells (Figure S11, Supporting Information). It was shown
that a short UV-irradiation time (<5 min) did not cause signiﬁ-
cant DNA damage, and the DNA proliferation capacity of MDA-
MB-231 cells and NIH 3T3 ﬁbroblasts reached more than 90%
after 48 h incubation. However, upon increasing irradiation time
(20 min), DNA damage was observed in the tested cell lines as a
function of incubation time. Therefore, a UV-irradiation time of
5 min was chosen for the following experiments.
The zeta (ζ )-potential and size were measured after each mod-
iﬁcation step of the nanoparticles (Figure 1B,C; Table S1, Sup-
porting Information). Brieﬂy, the surface charge reversed from
negative (−34.7 mV) to positive (+38.9 mV) after PEIylation.
Upon biotinylation, the ζ -potential was reduced to +32.1 mV.
Thiolation only slightly reduced the ζ -potential, in accordance
with former ﬁndings.[36] The ζ -potential decreased signiﬁcantly
to +5.1 mV upon PEGylation of the NPs, indicating that the pos-
itively charged surface was eﬀectively shielded by the PEG5000
corona. Finally, the PEGylated surface was converted into a zwit-
terionic surface after UV irradiation, leading to the change of the
ζ -potential to−3.7mV. The change in hydrodynamic diameter of
the NPs was also monitored. After PEI conjugation and PEGyla-
tion, the particle size increased by ca. 32 nm (from 159 to 191 nm)
and 53 nm (from 198 to 251 nm), respectively. After photolysis,
the size decreased by ca. 45 nm (from 251 to 206 nm). Transmis-
sion electron microscopy (TEM) images showed the structures
of the diﬀerent types of prepared NPs (Figure 1D). Brieﬂy, after
modiﬁcation by PEI and PEG, the porous structure of the Un-
THCPSi NPs was coated by the polymer layer and was not visible
in UPBP NPs. After photolysis, as the PEG corona was removed,
the porous structure reappeared.
The pH-dependent ζ -potential changes of the NPs with an-
tifouling surface is shown in Figure 1E. The ζ -potential of both
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Scheme 1. Fabrication process of UPBP NPs and the relevant chemical structures before and after photolysis.
kinds of NPs increased by reducing the pH values of the disper-
sion medium from 8.0 to 5.0 in phosphate buﬀer solution (PBS,
0.01 M). However, the ζ -potential of the zwitterionic NPs fea-
tured a sharp transition from−12.4mV to+17.2mV. In contrast,
the PEGylated NPs showed a slight transition of the ζ -potential
within the range of pH values studied. The generated zwitterionic
surface can maintain the surface charge close to neutral (from
−3.7mV to +2.5mV) within pH value from 7.4 to 6.8, which are
the typical pH value in normal tissue and malignant tissue, re-
spectively. This property is favorable to reduce the biomolecule
adsorption thermodynamically.[37]
2.2. NP−Protein Interaction Investigation and Colloidal
Stability of NPs
Next, NP−protein interaction was investigated by the addition of
10% human serum to mimic the serum-rich environment.9 In
addition to the PEGylated and zwitterionic NPs, the UnTHCPSi-
PEI-Biotin NPs (NPs without PEGylation) with cationic sur-
face served as the control NPs in this experiment, because the
cationic surface was prone to protein corona formation.[38] The
amount of protein adsorption of UnTHCPSi-PEI-Biotin NPs
was set as 100% in this comparison. As shown in Figures 1F
and Figure S12, Supporting Information, both the PEGylated
and zwitterionic NPs showed lower protein adsorption than the
cationic NPs at pH 7.4 and pH 6.8. The colloidal stability of the
UPBP NPs and Un-Bio@ZwS NPs were tested in HBSS buﬀer
(1 × Hank’s balanced salt solution, with 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid as buﬀering agent, pH = 7.4) and
10% human serum (Figure S13, Supporting Information). As a
result of the weak surface charge of both NPs, aggregation was
observed in HBSS buﬀer and human serum. However, the ten-
dency of aggregation was attenuated over time, suggesting that
the PEGylated and zwitterionic surfaces could maintain the col-
loid stability of the NPs. The colloidal stability also showed that
the size of Un-Bio@ZwS was smaller than that of UPBP NPs in
either protein-free or protein-rich environment.
2.3. Drug Loading Degree and Cumulative Drug Release Test
Based on the evaluation time of the photolysis-induced con-
version of acrylates-ortho-nitrobenzyl-PEG5000, it was expected
that photolysis-induced transformation of NPs’ surface (reduced
PEG density) could lead to correspondingly photo-triggered drug
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Figure 1. A) The time-evolution kinetics of acrylated-ortho-nitrobenzyl-PEG5000 photolysis (365 nm, 15–17 Mw cm−2). B) Size and relevant polydis-
persibility index (PDI) of the prepared NPs. C) ζ -potential of the prepared NPs. D) TEM images of the obtained NPs. E) Inﬂuence of diﬀerent pH values
on the ζ -potential of NPs with PEGylated and zwitterionic surfaces. F) Human serum proteins adsorption onto the NPs after 1 h incubation at 37 °C,
pH 7.4 or pH 6.8 (mean ± SD, n = 3). G) The cumulative release of SFN in 10% human serum.
release behavior. Firstly, the loading degree of a model anticancer
drug, sorafenib (SFN), was tested by immersing the NPs in
dimethyl sulfoxide (DMSO), reaching a drug loading of 23.7 ±
2.2% (mass ratio of SFN to NP). Then the drug release proﬁles of
UPBP NPs undergone diﬀerent UV-irradiation durations (0, 1,
3, 5, and 20min, the relevant UV dose was 0, 0.97, 2.91, 4.85, and
19.40 J cm−2) were determined in 10% human serum (Figure
1G). The UnTHCPSi-PEI-Biotin NPs served as a control. Due to
the strong aﬃnity between proteins and SFN molecules,[39] the
amount of SFN released from UnTHCPSi-PEI-Biotin NPs was
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as high as 75.5± 1.4% within 5 min, and reached a plateau at ca.
94% in 30 min. For UPBP NPs without UV photolysis, only ca.
35% of the payload was released after 12 h. The UV-irradiation
duration signiﬁcantly impacted the releasing proﬁles of SFN
from the UPBP NPs. Speciﬁcally, the longer the UV-irradiation
duration, the faster the release of SFN. The maximum amount
of SFN released was signiﬁcantly increased by increasing the
UV-irradiation duration to 20 min. Using 5 min photolysis, ca.
75.3% of payloads was released from UPBP NPs in 1 h; the
release proﬁle reached a plateau at ca. 83% after 8 h. After 20
min of photolysis, the amount of drug released from UPBP NPs
reached a plateau of ca. 85% in 1 h. It was noticed that the max-
imum amount of drug released from UPBP NPs after 20 min
photolysis was less than that from UnTHCPSi-PEI-Biotin NPs
(control). This lower level of release may be caused by the zwit-
terionic surface after photolysis, since the zwitterionic property
could prevent the interaction of proteins with the drug and limit
the drug release process.[40] The drug release proﬁle from UPBP
NPs following 5 min UV-exposing time in 10% human serum
was measured for 2 h (Figure S14, Supporting Information).
2.4. Biocompatibility of the Prepared NPs
The cytotoxicity of the prepared NPs was evaluated using NIH
3T3 ﬁbroblast (biotin-receptor negative cells) and MDA-MB-231
(biotin-receptor positive cells) cells at three time points (6, 24,
and 48 h; Figure 2).[24,41] In addition to the aforementionedUPBP
NPs andUn-Bio@ZwSNPs, the NPs without biotinmodiﬁcation
(UnTHCPSi-PEI-PEG NPs and UnTHCPSi-PEI-PEG after pho-
tolysis, which are termed as UPP NPs and Un@ZwS NPs), were
used as control groups to investigate the inﬂuence of the target-
ing molecules on the cytotoxicity.
Generally, the NPs with PEGylated surface (UPP and UPBP
NPs) showed good biocompatibility to both cell lines. Especially
at low concentrations (20 μg mL−1), the cell viability was more
than 95% after 48 h incubation. For the UPP and Un@ZwS NPs,
the photolysis-induced NPs toxicity was observed by prolong-
ing the incubation time and increasing the NPs concentration.
The diﬀerence in the cytotoxicity between UPP and Un@ZwS
NPs could be attributed to the shrinkage of particle size and the
exposure of the thiolated surface after photolysis, which could
enhance the cell internalization of NPs.[42–44] After modiﬁcation
with biotin, the cytotoxicity of Un-Bio@ZwS NPs was further in-
creased, especially for MDA-MB-231 cells, suggesting that the
active targeting segments could eﬃciently promote cell uptake
of the NPs. For NIH 3T3 ﬁbroblast cells that treated with Un-
Bio@ZwS NPs, reduced cell viability was also observed after 48 h
incubation, suggesting that the limited number of biotin recep-
tors could still promote the endocytosis process of the NPs.
2.5. The Eﬀect of Surface Properties and Environmental
Conditions on Cell Uptake of NPs
To further study the eﬀect of surface properties and environ-
mental conditions on cell uptake of NPs, ﬂow cytometry was
used to quantitatively determine the amount of internalized
NPs in both HBSS buﬀer and 10% human serum. In addition
to the aforementioned NPs, the positive-charged UnTHCPSi-
PEI-Biotin NPs served as a positive control to evaluate the cell
uptake eﬃciency of NPs without antifouling surface in serum-
free/serum-rich environment. The NPs were labeled with
ﬂuorescein isothiocyanate (FITC) for tracking. All the tested cell
samples were treated with trypan blue to quench the outer ﬂuo-
rescence signal before cell sorting. The net ﬂuorescence intensity
(NFI) was obtained by subtracting autoﬂuorescence of untreated
cells.
For the test in HBSS buﬀer (Figure 3A,B), the cell sorting data
showed that the uptake eﬃciency of UnTHCPSi-PEI-Biotin and
Un-Bio@ZwSNPs by both cell lineswas signiﬁcantly higher than
of the other NPs. For MDA-MB-231 cells, the NFI of UnTHCPSi-
PEI-Biotin and Un-Bio@ZwS NPs reached 1817 and 1051 (mean
value of ﬂuorescence intensity), respectively. As a result of the
positive charged surface ofUnTHCPSi-PEI-BiotinNPs, their NFI
was1.7 times of Un-Bio@ZwSNPs. For NIH 3T3 cells, this dif-
ference was even bigger. Due to the lack of the biotin receptors,
NIH 3T3 cells showed less uptake of Un-Bio@ZwS NPs. The
relevant NFI of UnTHCPSi-PEI-Biotin NPs was approximately
three times that of Un-Bio@ZwS NPs. However, the NFI of Un-
Bio@ZwS NPs was still higher than the rest of the groups with
antifouling surface (UPP, Un@ZwS, and UPBP NPs), suggest-
ing that the exposure of biotin segment could still facilitate the
uptake of NPs in normal cells, resulting in the oﬀ-target delivery
of NPs. For both cell clines, no signiﬁcant diﬀerence in uptake ef-
ﬁciency between UPP NPs and UPBP NPs was observed, which
meant that the PEG corona could eﬃciently block the active tar-
geting system. In comparison with UPP NPs, the Un@ZwS NPs
showed higher cell uptake eﬃciency. These observations are in
accordance with our former assumption that the enhanced NPs’
cytotoxicity was a result of the enhanced NPs’ cell uptake.
For both cell lines, the NFI of the UnTHCPSi-PEI-Biotin NPs
showed a drastic reduction in the presence of human serum
(Figure 3C,D). The reduction degree reached ca. 90% for both
cell lines, indicating that the active targeting system and posi-
tive charged surface were blocked by the protein corona. In con-
trast, the NFI reduction for the Un-Bio@ZwS NPs was only ca.
60% for both cell lines. Consequently, the cell uptake eﬃciency
of Un-Bio@ZwS NPs surpassed that of UnTHCPSi-PEI-Biotin
NPs with 2.3 times for MDA-MB-231 cells and 1.3 times for
NIH3T3 ﬁbroblasts. The higher cell uptake ofUn-Bio@ZwSNPs
indicated the reduced protein adsorption by the zwitterionic sur-
face, which could eﬃciently maintain the performance of active
targeting ligands.
The confocal ﬂuorescence imaging was also used for evalu-
ating the cell internalization eﬃciency to diﬀerent kinds of NPs
in HBSS buﬀer and 10% human serum (Figure 3E,F). Three
kinds of NPs were tested, including the UPBP, Un-Bio@ZwS,
and UnTHCPSi-PEI-Biotin NPs. The confocal images showed
that the cell internalization of the UPBP NPs in both cell lines
was very limited either in HBSS buﬀer or human serum. For
both the cell lines tested, signiﬁcant internalization inhibition
of UnTHCPSi-PEI-Biotin NPs was observed in human serum,
indicating that the formation of protein corona could eﬃciently
block the NP−cell interactions (e.g., speciﬁc interaction and
electronic adsorption). The relatively high extent of the NP inter-
nalization of Un-Bio@ZwS NPs in human serum indicated that
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Figure 2. Cell viability of 3T3 ﬁbroblast and MDA-MB-231 cells exposed to the diﬀerent NPs assessed by the CellTiter-Glo Luminescent Assay after 6,
24, and 48 h of incubation. Four concentrations of NPs (20, 50, 100, and 200 μg mL−1) were tested. Statistical analyses were made by one-way analysis
of variance (ANOVA) with Bonferroni post-hoc test. The levels of signiﬁcance were set at probabilities of *P <0.05, **P <0.01, and ***P <0.001. Data
are shown as mean ± S.D. (n = 3).
the speciﬁc targeting capacity wasmaintained on the zwitterionic
surface.
2.6. The Eﬀect of Surface Properties on NP−Macrophage
Interactions
Next, RAW 267.4 macrophages were used to evaluate the pos-
sible macrophages clearance eﬀect to the prepared NPs, by
ﬂuorescence-activated cell sorting in both HBSS buﬀer and 10%
human serum (Figure 4A,B) and confocal ﬂuorescence imaging
(Figure 4C). For the NPs with antifouling surface, but without ex-
posure of biotin (UPP, Un@ZwS, UPBP NPs), the macrophages
showed limited internalization in serum-free/serum-rich envi-
ronment, suggesting that the NPs with PEGylated or zwitte-
rionic surface could eﬃciently avoid the macrophages’ clear-
ance. However, macrophages showed enhanced cell uptake to
Un-Bio@ZwS NPs, compared with Un@ZwS NPs in serum-
free/serum-rich environment. Unlike MDA-MB-231 cells and
NIH 3T3 ﬁbroblasts that showed sharp uptake reduction to
UnTHCPSi-PEI-Biotin NPs after protein opsonization, the RAW
267.4 macrophage still showed the highest uptake eﬃciency to
UnTHCPSi-PEI-Biotin NPs than the other NPs in 10% human
serum, with only ca. 54% reduction of cell uptake compared
with that in serum-free buﬀer. This phenomenon conﬁrmed that
the macrophages could eﬃciently capture the opsonized NPs, in
view of the various overexpressed receptors for protein corona
recognition.[45]
2.7. Antiproliferation Test of the Sorafenib-Loaded NPs
The drug (SFN) delivery eﬃciency of the UPBP system
(SFN@UPBP NPs) was investigated in both HBSS buﬀer and
10% human serum using an antiproliferation test on MDA-MB-
231 cells (Figure 5). The NPs transformation-induced cancer cell
antiproliferation eﬀect could be observed in both environments.
This eﬀect indicated that the PEGylated surface could improve
the safety of NP-based formulation and restrict unexpected drug
release. After photolysis, the NPs transformed into the active tar-
geting form, thus promoting the cell internalization of NPs and
enhancing the corresponding anticancer eﬀect signiﬁcantly.
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Figure 3. A–D) Flow cytometry quantitative analysis of MDA-MB-231 cells and 3T3 ﬁbroblast in HBSS buﬀer and human serum. The cells were incubated
with the NPs for 6 h at 37 °C. Data are shown as mean ± SD (n = 3). The levels of signiﬁcance were set at probabilities of *P <0.05, **P <0.01, and
***P <0.001. Data are shown as mean ± SD (n = 3). E) and F) Confocal ﬂuorescence microscope images of MDA-MB-231 cells and 3T3 ﬁbroblast
treated with FITC-labeled NPs for 6 h at 37 °C (red: cell membranes stained with CellMask Deep Red; green: FITC-labeled NPs; yellow: co-localization of
the NPs and the cell membrane).
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Figure 4. A) and B) Flow cytometry quantitative analysis of RAW 267.4 macrophages in HBSS buﬀer and human serum. The cells were incubated with the
NPs for 6 h at 37 °C. Data are shown as mean± SD (n= 3). The levels of signiﬁcance were set at probabilities of *P<0.05, **P<0.01, and ***P<0.001.
Data are shown as mean ± SD (n = 3). C) Confocal ﬂuorescence microscope images of RAW 267.4 macrophage cells treated with FITC-labeled NPs for
6 h at 37 °C (red: cell membranes stained with CellMask Deep Red; green: FITC-labeled NPs; yellow: co-localization of the NPs and the cell membrane).
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Figure 5. Cancer cell growth inhibition by treatment of MDA-MB-231 cells with free SFN and SFN-loaded UPBP NPs in HBSS buﬀer and human serum,
with and without UV irradiation. Three diﬀerent concentrations of the NPs (5, 10, and 20 μg mL−1) were tested. The concentrations of the free drugs
were based on the relevant drug loading degrees in the NPs. The MBA-MB-231 cells were exposed to the NPs for 6, 24, and 48 h at 37 °C. The levels of
signiﬁcance were set at probabilities of *P <0.05, **P <0.01, and ***P <0.001. Data are shown as mean ± SD (n = 3).
For the comparison between free SFN and photolyzed
SFN@UBPB NPs in HBSS buﬀer, as the cells directly espoused
to SFN, free SFN exhibited a better therapeutic eﬀect than SFN-
loaded NPs. However, with prolonged incubation time, this dif-
ference was narrowed, and no signiﬁcant diﬀerences between the
groups of free drug and SFN-loaded NPs after 48 h incubation for
concentrations of 10 and 20 μg mL−1 were observed. In human
serum, as most of the SFN molecules form protein−drug com-
plexes in serum-rich environment,[46] and as a result of the in-
eﬃcient cell internalization to proteins,[47] the uptake of SFN de-
creased and the therapeutic eﬀect of SFNwas inhibited.However,
compared with the free drug, SFN-loaded NPs at high concentra-
tion (20 μg mL−1) showed higher cytotoxicity to cancer cells, in-
dicating that the targeting traﬃc by NPs wasmore eﬃcient in the
delivery of SFN into the cells in the protein-rich environment.
3. Conclusion
We have successfully engineered a photo-triggered trans-
formable system with sequential antifouling surface to better
modulate the NP–cell interactions in protein-rich environment.
This sequential antifouling surface can minimize the inﬂuence
of opsonization during the whole transition process of NPs.
In the in vitro assays with serum, we demonstrated that the
PEGylated surface could eﬀectively avoid the clearance from
macrophages and unfavorable oﬀ-target eﬀect. The secondary
antifouling surface generated by photo-triggered zwitterization
could preserve the targeting speciﬁcity of the NPs. It is expected
that the photo switchable system can be further developed into
a series of polycationic polymer-o-NB-based systems to achieve
photo-triggered zwitterization for constructing sequential an-
tifouling surface. Furthermore, to avoid the potential immuno-
genicity of PEG, the o-NB-based linker is also chemical achievable
to graft other polymers to construct the primary antifouling sur-
face, such as poly(carboxybetaine)[48] to obtain a better therapeu-
tic performance. In addition, beneﬁting from the development
of two-photon technology and NIR-UV upconversion technology,
the photo-triggered zwitterization can be achieved in deep tissue
and the DNA-damage caused by UV irradiation can be avoided.
As a proof-of-concept, this study demonstrated that the trans-
formable NPs with sequential antifouling surface may own great
potential to improve the clinical performance of the drug delivery
systems.
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4. Experimental Section
Materials: All the chemical reagents were purchased with the high-
est grade available from Sigma Aldrich and used without further pu-
riﬁcation. Sorafenib (SFN) was purchased from LC laboratories (USA).
Hank’s balanced salt solution (10 × HBSS), Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM), Roswell Park Memorial Institute (RPMI), Dulbecco’s
phosphate buﬀer saline (10 × PBS), fetal bovine serum (FBS), trypsin
(2.5%), nonessential amino acids (100 × NEAA), l-glutamine (200 mM),
and penicillin-streptomycin (100 × PEST) were all purchased from Hy-
Clone (USA). Versene was purchased from Life Technologies (USA). Try-
pan blue was purchased from MP Biomedicals (Germany). The MDA-
MB-231 breast carcinoma cells, NIH 3T3 ﬁbroblasts, and RAW 267.4
macrophages were obtained from American Type Culture Collection.
Chemical Characterization: 1HNMR spectra weremeasured on a Bruker
AV-400MHz spectrometer. Chemical shifts were recorded in ppm. Tetram-
ethylsilane (TMS) is used as an internal standard. Coupling constants
are given in Hz. MALDI-TOF mass spectra were acquired using an Ap-
plied Biosystems Voyager System 6069 MALDI-TOF mass spectrometer.
α-Cyano-4-hydroxycinnamic acid (CHCA) was used as matrix in all cases.
Sample concentrations were 0.3 mg mL−1.
The hydrodynamic size (z-average), polydispersity index (PdI), and ζ -
potential distribution of the NPs were measured by Zetasizer Nano ZS
(Malvern Instruments Ltd.). The relevant data were recorded as the aver-
age of three measurements.
The structure of the fabricated NPs was characterized by TEM under
an acceleration voltage of 120 kV. The NPs samples were prepared by
depositing them onto carbon-coated copper grids (300 mesh; Electron
Microscopy Sciences, USA) and contrasting with 2% uranyl acetate so-
lution. The NP-coated grids were dried at room temperature before the
TEM imaging.
The surface chemical modiﬁcations were characterized using Fourier
transform infrared spectroscopy (FTIR; Bruker Vertex 70). The KBr pellets
were processed bymixing 300μg of the samples with 200mg of KBr (spec-
troscopy grade, Sigma-Aldrich, Finland). FTIR spectra were recorded from
3500 to 600 cm−1 with a resolution of 4 cm−1 at room temperature using
OPUS 5.5 software.
Synthesis of the Photocleavable Acrylates-Ortho-Nitrobenzyl-PEG5000: The
synthesis of the photocleavable acrylates-ortho-nitrobenzyl-PEG5000 is out-
lined in Figure S1, Supporting Information. The mPEG5000 for forming
protective PEG corona and acrylate for further modiﬁcation on NPs were
added to the nitrobenzyl alcohol. Both 1H NMR spectrum (Figures S2–
S6, Supporting Information) and MALDI-TOF mass spectrum (Figures S7
and S8, Supporting Information) conﬁrmed the chemical structures dur-
ing the synthesis. The detailed synthesis methods are listed in Supporting
Information.
Preparation of UnTHCPSi NPs: The preparation of UnTHCPSi NPs was
done via electrochemical anodization, as described in detail elsewhere.[49]
Fabrication of the Photo-Triggered Zwitterization-Induced Sequential
Antifouling Surface on UnTHCPSi NPs: The UnTHCPSi NPs were ﬁrstly
activated by carbodiimide chemistry based on N-hydroxysuccinimide
(NHS) and 1-ethyl-3-(3-(dimethylamino)propyl)-carbodiimide (EDC).
Brieﬂy, 1 mg of UnTHCPSi NPs was activated by 10 μL of EDC for 20 min
and then reacted with 2 mg of NHS in 1 mL of anhydrous dimethylfor-
mamide (DMF) for 24 h. The UnTHCPSi-NHS ester NPs were harvested
by centrifugation (Sorvall RC 5B plus, Thermo Fisher Scientiﬁc, USA)
at 13 000 × g for 5 min, washed three times with anhydrous DMF. The
obtained UnTHCPSi-NHS ester NPs was then dispersed into 1 mL DMF
with 10 mg polyethylenimine dissolved beforehand. After 12 h stirring,
the obtained UnTHCPSi-PEI NPs were harvested by the aforementioned
procedures.
One milligram of UnTHCPSi-PEI NPs was suspended in 1 mL of an-
hydrous DMF, then 10 μg of Biotin-NHS ester was added into the sus-
pension. After 12 h stirring, the obtained UnTHCPSi-PEI-Biotin NPs were
harvested by the aforementioned procedures.
The thiolation of the UnTHCPSi-PEI-Biotin NPs was operated under Ar
atmosphere. One milligram of NPs was dispersed in 1 mL of phosphate
buﬀer saline (PBS, pH 7.4, 0.01M) and then the Traut’s reagent was added
(10 mg, 0.073 mmol). After 2 h, the NPs were harvested by centrifugation
at 13 000 × g for 5 min, and washed by PBS (pH 7.4, 0.01 M) three times
under Ar atmosphere. The obtained UnTHCPSi-PEI-Biotin-SH NPs was
dispersed in PBS (pH 7.8, 0.01 M) with the concentration of 1 mg mL−1.
Tenmilligrams of the acrylates-ortho-nitrobenzyl-PEG5000 (0.002mmol)
was added into the prepared UnTHCPSi-PEI-Biotin-SH NPs suspension.
The mass ratio of the PEG to NPs was 10:1. The reaction was processed
under Ar atmosphere for 24 h. The NPs was harvested by aforementioned
method and then stocked in ethanol (99%) with Ar protection.
UV Irradiation: The UV-irradiation condition in this study was 365 nm
and 15–17 mWcm−2.
Time-Evolution of the Photolysis-Induced Conversion of the Acrylates-
Ortho-Nitrobenzyl-PEG5000: A solution of acrylates-ortho-nitrobenzyl-
PEG5000 (100 μM) in PBS was irradiated for 3 min, followed immediately
by HPLC analysis. HPLC analysis was performed using a Shimadzu HPLC
setup equipped with two LC-8A series pumps coupled to a Shimadzu
ELSD-LT II detection system. Separation (Kinetex 5μ EVO, C18 100A, 150
× 4.6 mm, ﬂow rate: 1 mL min−1), in all instances, was carried out over
a linear gradient of 10–95% B over 20 min with an initial 5 min hold at
10% B. HPLC mobile phases: A—H2O (0.1% TFA); B—Acetonitrile (0.1%
TFA). The same sample was then re-irradiated and this cycle was repeated
for cumulative irradiation time points of 5, 10, 15, and 20 min. The con-
version of compound was calculated by the peak area of start material in
each trace.
Cell Culturing: The MDA-MB-231 breast cancer cells, NIH 3T3 ﬁ-
broblasts, and RAW 267.4 macrophages were cultured in 75 cm2 ﬂasks
(Corning Inc. Life Sciences, USA) in a standard BB 16 gas incubator (Her-
aeus Instruments GmbH, Germany) set at 95% humidity, 5% CO2, and
37 °C. MDA-MB-231 cells were cultured in standard RPMI 1640 medium,
NIH 3T3 ﬁbroblasts and RAW 267.4 macrophages were cultured in DMEM
medium, both supplemented with 10% v/v fetal bovine serum (FBS), 1%
nonessential amino acids, 1% l-glutamine, penicillin (100 IU mL−1), and
streptomycin (100 mgmL−1) (all fromHyClone, USA). Cells’ subculturing
was conducted at 80% conﬂuency, harvested prior to cell passaging and
each experiment with trypsin−PBS−ethylenediaminetetraacetic acid.
UV-Induced DNA Damage: The detection of DNA damage by UV was
made using the BrdU (5-bromo-2′-deoxyuridine) ELISA-based assay kit
(Millipore, Corporation, MA, USA). For this test, 100 μL of the cells were
plated and cultured at a concentration of 2 × 105 cell mL−1 in 96-well
plates at 37 °C. Various UV-irradiation dose (1.8, 3.0, 6.0, 12.0 J cm−2)
were then used to treat each group. After the relevant incubation times (6,
24, and 48 h), the BrdU reagent were added to culture medium, with a ﬁ-
nal concentration of 3μmL−1. Then the cells were incubated for 2 h. Then
the cells were ﬁxed with a ﬁxative solution and the DNA was denatured in
one-step by adding 200μL well−1 of the ﬁxative solution and incubation at
room temperature for 30 min. After three-time washings, 100 μL well−1 of
anti-BrdUmonoclonal antibody was added to bind to the BrdU in the newly
synthesized cellular DNA. Then, peroxidase-labeled goat anti-Mouse IgG
was added tomake immune complexes detectable after 30min incubation
with 100 μL well−1 of TMB peroxidase substrate at room temperature in
the dark. Finally, the reaction product was quantiﬁed by the addition of 2
N hydrochloric acid stop solution and measuring the absorbance using
a microplate reader (Varioskan Flash) at a wavelength of 525 nm. HBSS
treated cells were used as negative controls.
The pH-Dependent ζ -Potential Changes of the NPs: The NPs solutions
were diluted to 25 μg mL−1 using PBS of pH 5.0, 6.0, 6.8, 7.4, and 8.0,
respectively, and then incubated at 37 °C. Then the NPs solutions were
measured by a Zetasizer Nano ZS. Each measurement was performed for
30 runs, and the results were processed with DTS software.
Protein Adsorption of the NPs: The NPs were incubated with 10% human
serum at pH 6.8 or 7.4, with the ﬁnal concentration of NPs at1 mg mL−1.
After incubation at 37 °C for 1 h, 200 μL of each sample were centrifuged
at 13 000 × g for 5 min to precipitate the protein adsorbed NPs. The
protein concentration of supernatant was determined using UV-Vis
spectroscopy (UV-1600 PB spectrophotometer, VWR) by measuring the
maximal absorbance at 280 nm wavelength. Then, the adsorbed proteins
on the NPs were calculated against a standard calibration curve of the
proteins.
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Drug Loading Degree: The loading degree of SFN was tested by an im-
mersion method. Twenty-ﬁve micrograms of SFN-loaded UPBP NPs was
suspended in 1 mL of DMF and stirred for 2 h. The supernatant then was
obtained after centrifugation, and the concentration of SFN was deter-
mined by HPLC. For HPLC, the column used for SFN detection was C18
(4.6 × 100 × 3 mm, Gemini-Nx plus C18, Phenomenex, USA), and the
mobile phase used consisted of 0.2% of triﬂuoroacetic acid (TFA; pH 2)
and acetonitrile (42:58, v/v) with the ﬂow rate of 1.0 mL min−1. The tem-
perature of the column and wavelength used for drug detection were 25
°C and 254 nm, respectively. The injected volume of the drug solution was
20 μL.
Drug Release of NPs Treated with UV Irradiation: The SFN-loaded UPBP
NPs was dispersed in Milli-Q water ﬁrst with the concentration of 50 μg
mL−1. Then the NP suspensions were irradiated for 1, 3, 5, and 20 min,
respectively. The treated NPs were then mixed with equivalent volume of
20% human serum to obtain the 10% human serum NPs suspension, fol-
lowed immediately by HPLC analysis. The method of HPLC analysis was
the same as the part of drug loading degree.
Colloid Stability of UPBP NPs and Un-Bio@ZwS NPs: Hank’s balanced
salt solution−4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HBSS–
HEPES) buﬀer (pH 7.4) and 10% human serum (pH 7.4) were used to
investigate the colloidal stability of the NPs with the NPs concentration of
25 μg mL−1. Then the NPs solutions were measured by a Zetasizer Nano
ZS. Each measurement was performed for 30 runs, and the results were
processed with DTS software.
In Vitro Cytotoxicity: To evaluate the biosafety of the NPs, the viability
of the MDA-MB-231 and NIH 3T3 ﬁbroblast cells was assessed by mea-
suring their ATP activity after exposure to the NPs. Hundred microliters of
the cell suspensions in cell media at a concentration of 2 × 105 cells per
mL were seeded in 96-well plates and allowed to attach overnight. After
the removal of the cell media, the wells were washed twice with HBSS–
HEPES buﬀer (pH 7.4), and then 100 μL of the tested NPs at the relevant
concentrations was added. After incubation, the reagent assay (100 μL;
CellTiter-Glo Luminescent Cell Viability Assay, Promega, USA) was added
to each well to assess the ATP activity. The luminescence was measured
using a Varioskan Flash (Thermo Fisher Scientiﬁc Inc., USA). Positive (1%
Triton X-100) and negative (HBSS–HEPES buﬀer, pH 7.4) controls were
also used and treated similarly as described above. At least three indepen-
dent measurements were conducted for each experiment.
Confocal Imaging and FACS: For confocal ﬂuorescence microscopy
imaging, MDA-MB-231, 3T3 ﬁbroblasts, and RAW 267.4 macrophages
were seeded in eight-chamber slides (Nunc Lab-Tek II Chamber Slide Sys-
tem, Thermo Scientiﬁc, Inc., USA). For cell seeding, 200 μL of the cells
suspension (2.5 × 104 cells mL−1) was added to each chamber. After in-
cubation for 24 h, the cells were washed twice with HBSS–HEPES buﬀer
(pH 7.4). Two-hundred microliters of ﬂuorescein isothiocyanate (FITC)–
labeled NPs (10 μg mL−1) was added to each chamber, and then the
samples were incubated for 6 h. After that, the cells were washed with
HBSS–HEPES buﬀer to remove noninteracting NPs. The cell membrane
was stained with CellMask Deep Red (Life Technologies, USA) by incubat-
ing the cells at 37 °C for 3 min. Next, the cells were washed twice with
the HBSS–HEPES buﬀer and ﬁxed with 2.5% glutaraldehyde at room tem-
perature for 20 min. Finally, the glutaraldehyde was washed away, and the
cells were stored with 200 μL of HBSS–HEPES buﬀer (pH 7.4). The cells
were observed under a confocal ﬂuorescence microscope (Leica inverted
SP5 II HCS A) using Ar (488 nm), HeNe (590 nm), and HeNe (633 nm)
lasers. The images were analyzed using ImageJ 1.47v (National Institute
of Health, USA).
For the cell uptake ﬂow cytometry analysis, MB-231 cells, 3T3 ﬁbrob-
lasts, and RAW 267.4 macrophages were seeded in six-well plates (Corn-
ing Inc., Life Sciences, USA). For cell seeding, 2.5 mL of the cells suspen-
sion (2 × 105 cells per mL) were added to each well. The cell culturing
process was based on the aforementioned method. After that, 1.5 mL of
UPMFANPs inHBSS–HEPES buﬀer with the concentration of 10μgmL−1
were added to each well and then the samples were incubated for relevant
time. After removing the NPs suspensions and washing twice with HBSS–
HEPES buﬀer, the cells were harvested and treated with trypan blue to
quench the ﬂuorescence of NPs adhered on cell surface. Flow cytometry
was performed with a LSR II ﬂow cytometer (BD Biosciences, USA) with
a laser excitation wavelength of 488 nm using a FACSDiva software. Ten
thousand events were obtained for each sample. Relevant data were an-
alyzed and plotted using FlowJo software (Tree Star Inc., USA). At least
three independent measurements were conducted for each experiment.
Cell Growth Inhibition: The cell growth inhibition performance of the de-
veloped nanocomposites was also monitored by measuring the antiprolif-
eration eﬀect of the free SFN and SFN-loaded UPBP NPs using the same
method explained above for the cellular toxicity studies. At least three in-
dependent measurements were conducted for each experiment.
Statistical Analysis: Quantitative data collected over multiple, indepen-
dent experiments are presented as mean ± standard deviation (SD). At
least three independent experiments (n= 3) were performed to obtain the
described results. Statistical signiﬁcance of the data was analyzed by a one-
way analysis of variance (ANOVA) with Bonferroni post-hoc test (Graph-
Pad Prism, GraphPad software Inc., CA, USA). The signiﬁcance level was
set at probabilities of *P < 0.05, **P < 0.01, and ***P < 0.001.
Supporting Information
Supporting Information is available from the Wiley Online Library or from
the author.
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